Healthcare & Medical

APAC Health Summit 2026

The Oxford Nanopore APAC Health Summit is an invitation-only meeting bringing together leaders from clinical genomics, healthcare, policy, and translational research to explore how genomics can move from insight to real-world healthcare impact across the region. With a focused one-day programme of plenary sessions, panel discussions, roundtables, and network…

Visit the official site
12Speakers
0Sponsors
3On the bill · sessions
12Companies · in total
§I

Speakers

Programmed at APAC, in alphabetical order.
Eric Joo
University of Melbourne
Jin-Wu Nam
Professor and Principal Investigator, Department of Life Science · Hanyang University
Joanne Ngeow
Senior Consultant, Division of Medical Oncology; Associate Professor (Genomic Medicine) · Lee Kong Chian School of Medicine, National Cancer Centre Singapore
Motohiro Kato
Physician-scientist · University of Tokyo
Naomichi Matsumoto
Professor of Genetics, Director Medical Genome Center · Yokohama City University
Neblina Sikta
Clinical Bioinformatician · Victorian Clinical Genetics Services (VCGS)
Ni-Chung Lee
Clinical Professor · National Taiwan University Hospital
Piers Blombery
Clinical and Laboratory Haematologist; Lead of Molecular Haematology Service and Wilson Centre for Blood Cancer Genomics · Peter MacCallum Cancer Centre
Richard Scott
CEO at Genomics England · Genomics England
Shuhua Xu
Professor of Human Population Genetics; Director, Center for Evolutionary Biology · Fudan University
Tony Roscioli
Clinical Genomicist and Geneticist; Group Leader, Neurogenomics · NSW Health Pathology Randwick Genomics / NeuRA
Zoe Ward
University of Auckland
§III

Agenda

Selected from 3 sessions on the bill.
  • Monday, 3 August 2026 | 2:45pm - 3:05pm

    Using Oxford Nanopore Technologies long-read sequencing to resolve unexplained hereditary colorectal cancer and polyposis syndrome patients

    Background: Current hereditary colorectal cancer multigene panel testing uses conventional short-read next-generation sequencing, which can miss complex genetic variations such as …

    Oxford Nanopore Industry Session
  • Monday, 3 August 2026 | 3:05pm - 3:25pm

    Genetic testing solves mystery of teens’ sudden deaths

    Oxford Nanopore Industry Session
  • Monday, 3 August 2026 | 3:25pm - 3:45pm

    Genome-wide phasing using routine clinical samples

    Accurate haplotype phasing is critical for clinical variant interpretation, particularly for resolving cis/trans relationships in recessive Mendelian disease. Long-read sequencing …

    Oxford Nanopore Industry Session
Intermission
Part the Second · For the Buyer

An audience of 12 companies, parsed from the program.

Twelve companies in attendance.

The numbers below are derived from the speakers, sponsors, and exhibitors on this page — cross-referenced into one ledger. They are the only thing here that 10times.com cannot tell you.

Who's in the room
0All threespeak · spons · exh
0Sponsoringsponsor only
12Companies Speakingspeaker only
Speakers by seniority

25% of the speakers carry senior titles — C-suite, Founder, VP, or Director-level.

  • C-suite18%
  • Director / Head of217%
  • Manager / Lead18%
  • Engineer · IC18%
  • Research / Science217%
  • Other roles542%

Of 12 on the bill · classified by free-text title

Most-represented companies
  1. 01Fudan University1V
  2. 02Genomics England1V
  3. 03Hanyang University1V
  4. 04Lee Kong Chian School of Medicine, National Cancer Centre Singapore1V
  5. 05National Taiwan University Hospital1V
  6. 06NSW Health Pathology Randwick Genomics / NeuRA1V
  7. 07Peter MacCallum Cancer Centre1V
  8. 08University of Auckland1V
  9. 09University of Melbourne1V
  10. 10University of Tokyo1V
  11. 11Victorian Clinical Genetics Services (VCGS)1V
  12. 12Yokohama City University1V
Sponsors by tier

Tiers were not disclosed for this event.